DR. DAVID MICHAEL ERLANGER, PH.D.
Social Work at 65 St, New York, NY
License number
New York 013210
Category
Social Work
Type
Clinical Neuropsychologist
Address
Address
3 E 65Th St SUITE 5B, New York, NY 10065
Phone
(212) 396-2766
(212) 396-2762 (Fax)
(212) 396-2762 (Fax)
Personal information
See more information about DAVID MICHAEL ERLANGER at radaris.comName
Address
Phone
139 W 82Nd St #9F, New York, NY 10024
139 W 82Nd St, New York, NY 10024
217 Connetquot Rd, Bayport, NY 11705
3 E 65Th St APT 5B, New York, NY 10065
139 W 82Nd St #9F, New York, NY 10024
Professional information
See more information about DAVID MICHAEL ERLANGER at trustoria.com
Chemistry And Biology Teacher
Chemistry And Biology Teacher
Location:
Greater New York City Area
Industry:
Primary/Secondary Education
Dr. David M Erlanger, New York NY - PHD
Dr. David M Erlanger, New York NY - PHD
Specialties:
Neuropsychology, Clinical Neuropsychology
Address:
3 E 65Th St SUITE 5B, New York 10065
(212) 396-2766 (Phone), (212) 396-2762 (Fax)
(212) 396-2766 (Phone), (212) 396-2762 (Fax)
Languages:
English
Neurological Pathology Diagnostic Apparatus And Methods
Neurological Pathology Diagnostic Apparatus And Methods
US Patent:
7087015, Aug 8, 2006
Filed:
Jan 31, 2000
Appl. No.:
09/494475
Inventors:
McDonald Comrie - Staten Island NY, US
David Michael Erlanger - New York NY, US
Darin F Kaplan - New York NY, US
Vladislav Shchogolev - Brooklyn NY, US
Alexis Theodoracopulos - New York NY, US
Philip Yee - New York NY, US
David Michael Erlanger - New York NY, US
Darin F Kaplan - New York NY, US
Vladislav Shchogolev - Brooklyn NY, US
Alexis Theodoracopulos - New York NY, US
Philip Yee - New York NY, US
Assignee:
PanMedix, Inc. - New York NY
International Classification:
A61B 5/00
US Classification:
600300, 434236, 128904
Abstract:
Apparatus and methods for rapidly diagnosing the presence or absence of the symptoms of neurological pathology caused by physical head trauma (such as occurs in contact sports or automobile collisions), disease (such as occurs in Alzheimer's disease), toxins (substance abuse or environmental toxins) or infection (such as occurs as a side effect of later-stage AIDS infection). These inventions are useful for diagnosing neurological pathology, as well as for monitoring recovery from or maintenance or progression of neurological pathology.
Measuring Cognitive Impairment
Measuring Cognitive Impairment
US Patent:
2003007, Apr 17, 2003
Filed:
Sep 20, 2002
Appl. No.:
10/239383
Inventors:
Alexis Theodoracopulos - New York NY, US
Darin Kaplan - New York NY, US
Vladislav Shchogolev - Brooklyn NY, US
David Erlanger - New York NY, US
Philip Yee - New York NY, US
McDonald Comrie - Staten Island NJ, US
Darin Kaplan - New York NY, US
Vladislav Shchogolev - Brooklyn NY, US
David Erlanger - New York NY, US
Philip Yee - New York NY, US
McDonald Comrie - Staten Island NJ, US
International Classification:
A61B005/00
US Classification:
600/300000
Abstract:
System (s100, s200, s300, s400) to quantify cognitive performance.